Lilly Exec Says Tariffs Currently In Effect Do Not Materially Change 2025 Financial Outlook

May 1 (Reuters) - Eli Lilly and Co LLY.N:

• ELI LILLY EXEC SAYS ANNOUNCED TARIFFS CURRENTLY IN EFFECT DO NOT MATERIALLY CHANGE CO'S 2025 FINANCIAL OUTLOOK - CONF CALL

• LILLY EXEC SAYS EXPANSION OF TARIFFS IN OTHER GEOGRAPHIES OR INCREASES IN RETALIATORY TARIFFS WOULD HAVE A NEGATIVE EFFECT ON CO, INDUSTRY

• LILLY EXEC SAYS RECENTLY INITIATED LIMITED MOUNJARO LAUNCH IN CHINA, EXPECT TO TO GRADUALLY INCREASE LAUNCH IN H2 AS SUPPLY BECOMES AVAILABLE

• LILLY EXEC SAYS EXPECT US REGULATORY ACTION FOR MODIFIED DOSING REGIME FOR ALZHEIMER'S DRUG KISUNLA IN THE NEXT FEW MONTHS

• LILLY EXEC SAYS PLANS TO START A NEW LATE-STAGE TRIAL FOR ITS DRUG RETATRUTIDE IN PATIENTS WITH OBESITY AND CHRONIC LOW BACK PAIN

• LILLY EXEC SAYS CO HAS WITHDRAWN US APPLICATION FOR HEART FAILURE WITH PRESERVED EJECTION FRACTION INDICATION FOR TIRZEPATIDE